ArticleCurrent microbiology2025
Genome Analysis and Characterization of Enterococcus sp. SB12 Isolated from Carpathian Artisanal Cheese.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of probiotics is becoming increasingly popular in animal husbandry and medicine and is offered as an alternative to antibiotics. Due to the ability to produce bacteriocins with antimicrobial effects and survival in the gastrointestinal tract, certain strains of Enterococcus faecium are used in probiotics to prevent diseases of the digestive system. Here, we present the genomic analysis and characterization of Enterococcus sp. SB12 isolated from Carpathian cheese. Whole-genome sequencing and analysis revealed that the genome of strain SB12 is represented by one circular chromosome and two circular plasmids, with a total size of 2.69 Mb. Phylogenetic analysis positioned Enterococcus sp. SB12 within a clade of Enterococcus strains with recognized probiotic potential. The genome analysis identified several antibiotic resistance genes (AAC(6')-Ii, vanY in vanB cluster, efrA, eatAv). Several virulence factors were also identified in the genome; however, none of them were major virulence factors typically found in clinical E. faecium strains. In addition, we identified clusters of genes for the synthesis of bacteriocins: enterocin A, enterocin SE-K4, enterocin P, enterolysin A, and enterocin L50. The Enterococcus sp. SB12 strain showed a limited capacity for tyrosine decarboxylation. Notably, this strain also showed resistance to high temperatures, salinity, lysozyme and low pH.
Indexed as
Identifiers
40580365What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.